Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 2667522)

Published in Biochem Pharmacol on August 01, 1989

Authors

J P Henry1, D Scherman

Author Affiliations

1: Institut de Biologie Physico-Chimique, CNRS UA, Paris, France.

Articles citing this

Proton-dependent multidrug efflux systems. Microbiol Rev (1996) 8.81

Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A (1992) 1.95

Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J (2006) 1.78

Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1. J Physiol (2013) 1.25

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. Am J Psychiatry (2011) 0.93

Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. Curr Top Med Chem (2011) 0.93

The adrenal chromaffin granule: a model for large dense core vesicles of endocrine and nervous tissue. J Anat (1993) 0.90

Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition. Schizophr Bull (2012) 0.89

Processing of chromogranins in chromaffin cell culture: effects of reserpine and alpha-methyl-p-tyrosine. Biochem J (1996) 0.89

Manganism in the 21st century: the Hanninen lecture. Neurotoxicology (2013) 0.83

High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. Biochem J (1998) 0.81

Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine. Br J Pharmacol (1991) 0.80

Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET. PLoS One (2013) 0.79

Spiroindolines identify the vesicular acetylcholine transporter as a novel target for insecticide action. PLoS One (2012) 0.79

PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133). PLoS One (2012) 0.78

Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats. Psychopharmacology (Berl) (2006) 0.78

Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus. Br J Pharmacol (1994) 0.77

Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter. PLoS One (2017) 0.75

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain. Transl Psychiatry (2017) 0.75

Neuromythology of Manganism. Curr Epidemiol Rep (2015) 0.75

Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery. Saudi Pharm J (2016) 0.75

Articles by these authors

(truncated to the top 100)

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16

High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31

Protective role of interleukin-10 in atherosclerosis. Circ Res (1999) 3.28

Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat Biotechnol (2001) 1.91

Association of the GTP-binding protein Rab3A with bovine adrenal chromaffin granules. Proc Natl Acad Sci U S A (1990) 1.58

Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res (2000) 1.55

A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther (1997) 1.53

Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res (1999) 1.38

Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc Natl Acad Sci U S A (1997) 1.29

Oxonol-V as a probe of chromaffin granule membrane potentials. Biochim Biophys Acta (1980) 1.28

Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding. Mol Pharmacol (1984) 1.28

Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine. Proc Natl Acad Sci U S A (1983) 1.21

Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha. Bioconjug Chem (1999) 1.14

Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther (1999) 1.14

pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther (1999) 1.13

Synthesis, activity, and structure--activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem (1998) 1.13

Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08

Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08

Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. Proc Natl Acad Sci U S A (1999) 1.08

Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III (1998) 1.07

Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta (1998) 1.05

Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med (2007) 1.02

Reducible cationic lipids for gene transfer. Biochem J (2001) 1.02

Electrotransfer into skeletal muscle for protein expression. Curr Gene Ther (2006) 1.00

Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer. J Gene Med (2001) 0.98

Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis (2007) 0.98

Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol (1994) 0.97

High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther (1994) 0.97

Reduction-sensitive lipopolyamines as a novel nonviral gene delivery system for modulated release of DNA with improved transgene expression. J Med Chem (2000) 0.96

Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol Toxicol (1998) 0.96

Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography. Gene Ther (1997) 0.96

Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med (2000) 0.94

Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum Gene Ther (1995) 0.94

Synaptin/synaptophysin, p65 and SV2: their presence in adrenal chromaffin granules and sympathetic large dense core vesicles. Biochim Biophys Acta (1991) 0.92

Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection. J Gene Med (2000) 0.92

Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol (2006) 0.92

Effect of drugs on the ATP-induced and pH-gradient-driven monoamine transport by bovine chromaffin granules. Biochem Pharmacol (1980) 0.92

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Ther (2010) 0.92

Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry (1989) 0.92

Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine (2001) 0.91

Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol (2006) 0.91

In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther (2005) 0.90

Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J Gene Med (2001) 0.90

High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther (2000) 0.90

Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta (2004) 0.90

Gene transfer by naked DNA into adult mouse brain. Gene Ther (1996) 0.89

Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules. Biochem Pharmacol (1988) 0.89

Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol (1986) 0.89

Existence of an adenosine 5'-triphosphate dependent proton translocase in bovine neurosecretory granule membrane. Biochemistry (1982) 0.89

Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther (2001) 0.89

Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J Neurochem (1986) 0.88

Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation. FEBS Lett (1999) 0.88

Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. Blood (2001) 0.88

Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann N Y Acad Sci (1987) 0.88

Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer. Infect Immun (2009) 0.87

pH-dependence of the ATP-driven uptake of noradrenaline by bovine chromaffin-granule ghosts. Eur J Biochem (1981) 0.86

Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation. Gene Ther (2003) 0.86

Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J Neurochem (1996) 0.86

The catecholamine transporter of adrenal medulla chromaffin granules. Ann N Y Acad Sci (1994) 0.86

Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. Mol Pharmacol (1988) 0.86

Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol (2004) 0.86

Sympathetic axons and nerve terminals: the protein composition of small and large dense-core and of a third type of vesicles. Neuroscience (1990) 0.85

Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Exp Cell Res (1995) 0.85

[3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Neurosci Lett (1990) 0.85

Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery. Gene Ther (2009) 0.85

Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther (1999) 0.84

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy. J Neurol Sci (1988) 0.84

Efficient DNA electrotransfer into tumors. Bioelectrochemistry (2000) 0.84

Novel method for covalent fluorescent labeling of plasmid DNA that maintains structural integrity of the plasmid. Bioconjug Chem (2000) 0.84

Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol (2001) 0.83

Intracellular fate and nuclear targeting of plasmid DNA. Cell Biol Toxicol (1999) 0.83

A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med (2006) 0.83

Rat adrenal medulla: levels of chromogranins, enkephalins, dopamine beta-hydroxylase and of the amine transporter are changed by nervous activity and hypophysectomy. Neuroscience (1987) 0.83

Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency. Bioorg Med Chem Lett (2000) 0.83

Internal pH of isolated newly formed and aged neurohypophysial granules. Proc Natl Acad Sci U S A (1982) 0.83

Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin. Neuroscience (1989) 0.82

Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane. Biochemistry (1985) 0.82

Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis. Arthritis Rheum (2011) 0.81

Production of a new DNA vehicle for gene transfer using site-specific recombination. Appl Microbiol Biotechnol (1998) 0.81

The catecholamine carrier of bovine chromaffin granules. Form of the bound amine. Mol Pharmacol (1983) 0.81

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography. Brain Res (1994) 0.81

Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene. Gene Ther (2009) 0.81

Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic mice. J Gene Med (2007) 0.81

Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J (2005) 0.81

Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter. Eur J Pharmacol (1996) 0.80

Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis. Gene Ther (2009) 0.80

High-resolution magnetic resonance imaging of knee inflammatory arthritis in mice. Clin Exp Rheumatol (2006) 0.80

Role of the proton electrochemical gradient in monoamine transport by bovine chromaffin granules. Biochim Biophys Acta (1980) 0.80

Anionic pH-sensitive pegylated lipoplexes to deliver DNA to tumors. Int J Pharm (2008) 0.79

Neutral postgrafted colloidal particles for gene delivery. Bioconjug Chem (2005) 0.79

Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells. Eur J Pharmacol (1995) 0.79

Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling. J Neurochem (1992) 0.79

Factors influencing the oligonucleotides release from O-W submicron cationic emulsions. J Control Release (2001) 0.78

[Effect of transmembrane potential on noradrenaline transport in chromaffin granules]. C R Seances Acad Sci D (1979) 0.78

Acido-basic properties of the catecholamine uptake inhibitors tetrabenazine and dihydrotetrabenazine. Biochimie (1982) 0.78

Synthesis of new cationic lipids from an unsaturated glycoside scaffold. Org Lett (2001) 0.78

Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biol Toxicol (1994) 0.78

Synthesis and biological properties of new glycosidic cationic lipids for DNA delivery. Bioorg Med Chem Lett (2000) 0.78

Solubilization of the catecholamine carrier of chromaffin granule membranes in a form that binds substrates and inhibitors of uptake. Biochemistry (1983) 0.78

Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Ther (2002) 0.78